FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2113241465> ?p ?o ?g. }

• W2113241465 endingPage "412" @default.
• W2113241465 startingPage "407" @default.
• W2113241465 abstract "Objective To determine if there is an association between plasma HIV-1 RNA levels and severity of HIV-associated distal symmetrical polyneuropathy (DSP). Design Substudy of AIDS Clinical Trials Group Protocol 291, a double-blind, placebo-controlled study of recombinant human nerve growth factor for the treatment of painful DSP. Methods Two-hundred and thirty-six subjects had plasma HIV-1 RNA load assayed at baseline. Mean and maximum neuropathic pain was assessed once daily by the Gracely Pain Scale. Other measures included subjects’ global pain assessment and quantitative sensory tests (QST). These values were correlated with baseline HIV-1 RNA levels. Results Among 168 subjects with detectable plasma HIV-1 RNA, there was a significant correlation between plasma HIV-1 RNA and the severity of maximum and global pain, and toe cooling thresholds. Maximum and global pain assessment correlated with plasma HIV-1 RNA in individuals with detectable viral load (r, 0.162 and 0.194;P = 0.04 and 0.01, respectively). Conclusions There is an association between plasma HIV-1 RNA levels and the severity of pain and QST results in HIV-associated DSP. Further studies are needed to determine if aggressive use of antiretroviral drugs, including the use of dideoxynucleosides, may be of benefit to prevent or improve peripheral neuropathy." @default.
• W2113241465 created "2016-06-24" @default.
• W2113241465 creator A5000097172 @default.
• W2113241465 creator A5001813919 @default.
• W2113241465 creator A5003041862 @default.
• W2113241465 creator A5004681741 @default.
• W2113241465 creator A5006573109 @default.
• W2113241465 creator A5009003697 @default.
• W2113241465 creator A5012372114 @default.
• W2113241465 creator A5012623658 @default.
• W2113241465 creator A5014686861 @default.
• W2113241465 creator A5015669455 @default.
• W2113241465 creator A5015985715 @default.
• W2113241465 creator A5016344996 @default.
• W2113241465 creator A5016743645 @default.
• W2113241465 creator A5017120025 @default.
• W2113241465 creator A5017422398 @default.
• W2113241465 creator A5018052279 @default.
• W2113241465 creator A5019347256 @default.
• W2113241465 creator A5019873793 @default.
• W2113241465 creator A5027205500 @default.
• W2113241465 creator A5029043155 @default.
• W2113241465 creator A5030324367 @default.
• W2113241465 creator A5031126433 @default.
• W2113241465 creator A5033401066 @default.
• W2113241465 creator A5036286479 @default.
• W2113241465 creator A5037202487 @default.
• W2113241465 creator A5037592415 @default.
• W2113241465 creator A5037683606 @default.
• W2113241465 creator A5038368249 @default.
• W2113241465 creator A5041036157 @default.
• W2113241465 creator A5042232387 @default.
• W2113241465 creator A5044000196 @default.
• W2113241465 creator A5045389396 @default.
• W2113241465 creator A5045896185 @default.
• W2113241465 creator A5046827594 @default.
• W2113241465 creator A5047059686 @default.
• W2113241465 creator A5047809221 @default.
• W2113241465 creator A5048978566 @default.
• W2113241465 creator A5049131748 @default.
• W2113241465 creator A5050196572 @default.
• W2113241465 creator A5056308996 @default.
• W2113241465 creator A5056777805 @default.
• W2113241465 creator A5056899895 @default.
• W2113241465 creator A5056972176 @default.
• W2113241465 creator A5058144983 @default.
• W2113241465 creator A5058226785 @default.
• W2113241465 creator A5059878540 @default.
• W2113241465 creator A5063249640 @default.
• W2113241465 creator A5064420578 @default.
• W2113241465 creator A5065254952 @default.
• W2113241465 creator A5066408266 @default.
• W2113241465 creator A5066797968 @default.
• W2113241465 creator A5066975903 @default.
• W2113241465 creator A5068657251 @default.
• W2113241465 creator A5070549767 @default.
• W2113241465 creator A5071035150 @default.
• W2113241465 creator A5071686386 @default.
• W2113241465 creator A5072899489 @default.
• W2113241465 creator A5073567069 @default.
• W2113241465 creator A5076237489 @default.
• W2113241465 creator A5077048747 @default.
• W2113241465 creator A5077540938 @default.
• W2113241465 creator A5082228008 @default.
• W2113241465 creator A5084067321 @default.
• W2113241465 creator A5084581862 @default.
• W2113241465 creator A5084840739 @default.
• W2113241465 creator A5084993295 @default.
• W2113241465 creator A5087068600 @default.
• W2113241465 creator A5087449043 @default.
• W2113241465 creator A5087813701 @default.
• W2113241465 creator A5088660280 @default.
• W2113241465 creator A5088939001 @default.
• W2113241465 creator A5090348690 @default.
• W2113241465 date "2002-02-01" @default.
• W2113241465 modified "2023-10-11" @default.
• W2113241465 title "Severity of HIV-associated neuropathy is associated with plasma HIV-1 RNA levels" @default.
• W2113241465 cites W1587812553 @default.
• W2113241465 cites W1979092952 @default.
• W2113241465 cites W2001350842 @default.
• W2113241465 cites W2002377803 @default.
• W2113241465 cites W2024864390 @default.
• W2113241465 cites W2027582897 @default.
• W2113241465 cites W2034760164 @default.
• W2113241465 cites W2036738390 @default.
• W2113241465 cites W2078993207 @default.
• W2113241465 cites W2079641188 @default.
• W2113241465 cites W2081957638 @default.
• W2113241465 cites W2083737567 @default.
• W2113241465 cites W2092829017 @default.
• W2113241465 cites W2100388346 @default.
• W2113241465 cites W2105253702 @default.
• W2113241465 cites W2140969998 @default.
• W2113241465 cites W2142672496 @default.
• W2113241465 doi "https://doi.org/10.1097/00002030-200202150-00012" @default.
• W2113241465 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11834952" @default.
• W2113241465 hasPublicationYear "2002" @default.
• W2113241465 type Work @default.

• next